![PSA test gets a better grade from USPSTF—it's a “C” Uncertainty lingers about high-risk groups](https://cdn.cancerletter.com/media/2018/05/prostate-exam-web.jpg)
![PSA test gets a better grade from USPSTF—it's a “C” Uncertainty lingers about high-risk groups](https://cdn.cancerletter.com/media/2018/05/prostate-exam-web.jpg)
Cover Story
Relying largely on maturing data from the European trials of screening for prostate cancer, the U.S. Preventive Services Task Force has given a better grade—a “C”—to screening for prostate cancer.
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
Trending Stories
- Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot
- NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission